Drug · DIN 02474719
PENTHROX
SINGLE-DOSE BOTTLE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 18, 2026; first marketed June 13, 2018.
- Drug Identification Number (DIN)
- 02474719
- Company (DIN owner)
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Inhalation
- Therapeutic class (ATC)
- Methoxyflurane N02BG09
- Class
- Human
- Record last updated
- September 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| METHOXYFLURANE | 99.9 % |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 18, 2026: NOC 38127New Drug Submission (NDS) · Administrative: Change in product ownership
- April 21, 2022: NOC 28003New Drug Submission (NDS) · Administrative: Change in Product Ownership
- April 7, 2018: NOC 20719New Drug Submission (NDS)
Other DINs named PENTHROX
- DIN 02474727 · Marketed